The survey is the largest, most comprehensive study of the regulatory profession, and it is open to individuals anywhere in the world involved with the regulatory process for healthcare products. RAPS has conducted this research for more than 20 years. The data collected help regulatory professionals and the organizations that employ them to benchmark compensation against others in the field and better understand the wide range of responsibilities of those working in regulatory. The results also help RAPS support the development of the profession and create effective tools to support regulatory professionals’ career development.
“This research is critically important to understanding the changing roles and responsibilities of regulatory professionals in the healthcare product sector,” said RAPS Executive Director Sherry Keramidas, PhD, FASAE, CAE. “Regulatory expertise is highly valued among organizations that develop, manufacture and market pharmaceuticals, medical technology and other healthcare products. RAPS’ research has shown that the regulatory profession has developed rapidly to become a key player in business and strategic decisions.”
Results of the most recent Scope of Practice Survey in 2010 show regulatory professionals taking on a wider range of responsibilities, including critical business functions. In addition, their overall compensation continued to increase despite the recent economic downturn. More than 3,000 responses were received from 55 different countries to the 2010 survey.
The 2012 RAPS Global Scope of Practice & Compensation Survey is open now, and regulatory professionals can complete it online at www.raps.org/2012globalstudy. All participants may elect to receive a free copy of the final report. Those with the Regulatory Affairs Certification (RAC) credential will receive one recertification credit. The survey takes about 10 minutes to complete and is anonymous and confidential.
RAPS will announce the results of the 2012 survey later this year.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org
